WallStreetZenWallStreetZen

NYSEMKT: CLDI
Calidi Biotherapeutics Inc Stock Ownership - Who owns Calidi Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Calidi Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Allan CamaisaCEO and Chairman of the Board2024-12-1710,000$1.62
$16.20kSell
Allan CamaisaCEO and Chairman of the Board2024-09-2670,155$1.15
$80.68kBuy

1 of 1

CLDI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDI insiders and whales buy or sell their stock.

CLDI Shareholders

What type of owners hold Calidi Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Allan Camaisa338.41%8,965,668$15.60MInsider
James A. Schoeneck76.84%2,035,668$3.54MInsider
Scott Leftwich74.94%1,985,417$3.45MInsider
First Light Acquisition Group LLC72.92%1,931,852$3.36MInsider
Polar Asset Management Partners Inc32.53%861,800$1.50MInsider
Armistice Capital LLC29.89%792,000$1.38MInstitution
Thomas A. Vecchiolla26.75%708,792$1.23MInsider
Stephen Thesing17.80%471,544$820.49kInsider
Boris Radoslavov Minev16.02%424,458$738.56kInsider
Bank Of Montreal15.95%422,500$735.15kInstitution

1 of 3

CLDI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDI13.28%86.72%Net Buying
ONCO0.15%99.85%
XBIO1.56%98.44%
BCTX0.93%66.64%
GLTO1.95%98.05%Net SellingNet Selling
View Top Biotech Stocks

Calidi Biotherapeutics Stock Ownership FAQ

Who owns Calidi Biotherapeutics?

Calidi Biotherapeutics (NYSEMKT: CLDI) is owned by 107.72% institutional shareholders, 703.52% Calidi Biotherapeutics insiders, and 0.00% retail investors. Allan Camaisa is the largest individual Calidi Biotherapeutics shareholder, owning 8.97M shares representing 338.41% of the company. Allan Camaisa's Calidi Biotherapeutics shares are currently valued at $15.60M.

If you're new to stock investing, here's how to buy Calidi Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.